Edition:
India

Genfit SA (GNFT.PA)

GNFT.PA on Paris Stock Exchange

20.80EUR
8:20pm IST
Change (% chg)

€1.55 (+8.05%)
Prev Close
€19.25
Open
€19.50
Day's High
€21.78
Day's Low
€19.42
Volume
521,188
Avg. Vol
112,525
52-wk High
€28.28
52-wk Low
€17.67

Chart for

About

Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect... (more)

Overall

Beta: 1.59
Market Cap(Mil.): €769.50
Shares Outstanding(Mil.): 31.17
Dividend: --
Yield (%): --

Financials

BRIEF-Genfit's Q1 revenues edge up compared to a year ago

* Revenues for the first three months of 2018 amounted to €37 thousand compared to €26 thousand for the same period in 2017

27 Apr 2018

BRIEF-Genfit Announces Positive Outcome From The Safety Review By The DSMB

* REG-GENFIT : POSITIVE OUTCOME FROM THE 24-MONTH PRE-PLANNED SAFETY REVIEW BY THE DSMB, IN RESOLVE-IT PHASE 3 CLINICAL TRIAL WITH ELAFIBRANOR

23 Apr 2018

Earnings vs. Estimates